Researchers have shown how the amygdala, a brain region typically associated with fear, contributes to prepulse inhibition (PPI) by activating small inhibitory neurons in the mouse brain stem. The discovery advances understanding of the systems underlying PPI and efforts to ultimately develop medical therapies for schizophrenia and other disorders by reversing pre-attentive deficits.